Bluejay Diagnostics, Inc. Quarterly Return On Equity in % from Q4 2021 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Bluejay Diagnostics, Inc. quarterly/annual Return On Equity history and growth rate from Q4 2021 to Q3 2024.
  • Bluejay Diagnostics, Inc. Return On Equity for the quarter ending September 30, 2024 was -156 %, a 25.2% decline year-over-year.
  • Bluejay Diagnostics, Inc. annual Return On Equity for 2023 was -168 %, a 174% decline from 2022.
  • Bluejay Diagnostics, Inc. annual Return On Equity for 2022 was -61.5 %, a 33.4% increase from 2021.
  • Bluejay Diagnostics, Inc. annual Return On Equity for 2021 was -92.2 %, a 395% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -156 -31.4 -25.2% Jul 1, 2024 Sep 30, 2024
Q2 2024 -187 -82.4 -78.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -218 -142 -184% Jan 1, 2024 Mar 31, 2024
Q4 2023 -168 -107 -174% Oct 1, 2023 Dec 31, 2023
Q3 2023 -124 -68.7 -123% Jul 1, 2023 Sep 30, 2023
Q2 2023 -105 -46.7 -80.7% Apr 1, 2023 Jun 30, 2023
Q1 2023 -76.8 -20.8 -37.1% Jan 1, 2023 Mar 31, 2023
Q4 2022 -61.5 +30.8 +33.4% Oct 1, 2022 Dec 31, 2022
Q3 2022 -55.7 Jul 1, 2022 Sep 30, 2022
Q2 2022 -57.9 Apr 1, 2022 Jun 30, 2022
Q1 2022 -56 Jan 1, 2022 Mar 31, 2022
Q4 2021 -92.2 Oct 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.